Company profile APRE
After 39 days of this quarter the interest is at 19.0. Based on that we can calculate that during remaining 52 days it will total up to 44.0. Aprea Therapeutics expected interest is significantly lower compared to same quarter last year (-65.6%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 29 | 38 31.0% QoQ | 135 255.3% QoQ | 123 -8.9% QoQ |
| 2020 | 148 410.3% YoY 20.3% QoQ | 107 181.6% YoY -27.7% QoQ | 85 -37.0% YoY -20.6% QoQ | 140 13.8% YoY 64.7% QoQ |
| 2021 | 421 184.5% YoY 200.7% QoQ | 299 179.4% YoY -29.0% QoQ | 264 210.6% YoY -11.7% QoQ | 163 16.4% YoY -38.3% QoQ |
| 2022 | 185 -56.1% YoY 13.5% QoQ | 110 -63.2% YoY -40.5% QoQ | 101 -61.7% YoY -8.2% QoQ | 69 -57.7% YoY -31.7% QoQ |
| 2023 | 128 -30.8% YoY 85.5% QoQ | 127 15.5% YoY -0.8% QoQ | 95 -5.9% YoY -25.2% QoQ | 38 -44.9% YoY -60.0% QoQ |
| 2024 | 19 -85.2% YoY -50.0% QoQ | - | - | - |
The average 5 years interest of Aprea Therapeutics was 10.82 per week. The last year interest of Aprea Therapeutics compared to the last 5 years has changed by -38.54%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -8.02%.
There is not enough data for ATRN-119 clinical trials to provide analysis
There is not enough data for ATRN-119 clinical trials to provide correlation calculation
There is not enough data for ATRN-119 clinical trials to provide analysis
There is not enough data for Aprea Therapeutics cancer therapeutics to provide analysis
There is not enough data for Aprea Therapeutics cancer therapeutics to provide correlation calculation
There is not enough data for Aprea Therapeutics cancer therapeutics to provide analysis
There is not enough data for Aprea Therapeutics advanced solid tumors to provide analysis
There is not enough data for Aprea Therapeutics advanced solid tumors to provide correlation calculation
There is not enough data for Aprea Therapeutics advanced solid tumors to provide analysis
There is not enough data for Aprea Therapeutics ovarian cancer to provide analysis
There is not enough data for Aprea Therapeutics ovarian cancer to provide correlation calculation
There is not enough data for Aprea Therapeutics ovarian cancer to provide analysis
There is not enough data for Aprea Therapeutics breast cancer to provide analysis
There is not enough data for Aprea Therapeutics breast cancer to provide correlation calculation
There is not enough data for Aprea Therapeutics breast cancer to provide analysis
There is not enough data for Aprea Therapeutics prostate cancer to provide analysis
There is not enough data for Aprea Therapeutics prostate cancer to provide correlation calculation
There is not enough data for Aprea Therapeutics prostate cancer to provide analysis
There is not enough data for Aprea Therapeutics -stock -company to provide analysis
There is not enough data for Aprea Therapeutics -stock -company to provide correlation calculation
There is not enough data for Aprea Therapeutics -stock -company to provide analysis
There is not enough data for Aprea Therapeutics careers to provide analysis
There is not enough data for Aprea Therapeutics careers to provide correlation calculation
There is not enough data for Aprea Therapeutics careers to provide analysis
There is not enough data for Aprea Therapeutics reviews to provide analysis
There is not enough data for Aprea Therapeutics reviews to provide correlation calculation
There is not enough data for Aprea Therapeutics reviews to provide analysis